Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Enovix Corp’s President and CEO Rajendra Talluri had 18,516 shares of common stock withheld on January 16, 2026 to cover taxes on vesting restricted stock units. The shares were withheld at a price of $8.24 per share and are classified as a disposition for tax withholding, not an open-market sale.
After this transaction, Talluri beneficially owns 2,224,738 Enovix shares. This total includes 1,536,188 shares issuable upon settlement of RSUs and 95,551 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027, each representing the right to receive one share upon settlement.
Enovix Corporation filed a current report describing a leadership change and preliminary 2025 revenue information. The company’s Chief Operating Officer, Ajay Marathe, informed Enovix on January 19, 2026 that he will retire effective February 17, 2026. The company states that his decision to retire is not due to any disagreement about its operations, policies or practices.
Enovix also furnished a press release that contains certain preliminary, unaudited financial information about its revenue growth during 2025. That press release is provided as an exhibit and is treated as furnished, not filed, under securities law, meaning it is not automatically subject to certain liability provisions or incorporated into other filings unless specifically referenced.
Talluri Rajendra K, President and CEO and director of Enovix Corporation (ENVX), reported a transaction on 09/18/2025 showing 17,617 shares of common stock disposed of at a price of $9.96. The filing explains these shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 2,368,301 shares, which includes 1,812,399 shares issuable upon settlement of outstanding RSUs. The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Insider transfer and holdings update: Thurman J. Rodgers, a director and greater-than-10% owner of Enovix Corporation, reported transactions on 09/18/2025. He transferred 5,635 shares to the Rodgers Massey Revocable Living Trust dated 4/4/11, of which he is trustee and retains voting and dispositive power. On the same date, 5,635 shares were acquired (reported as an acquisition at $0). Following these transactions, Rodgers directly holds 16,908 shares reported as issuable upon settlement of restricted stock units (RSUs) and indirectly holds additional shares through trust accounts, including 1,120,114 shares held in a trust and other trust-held shares, with total indirect beneficial ownership noted as 20,864,042 shares.
Enovix Corp insider Arthi Chakravarthy, the company's Chief Legal Officer, reported a transaction on 09/08/2025 in which 934 shares of common stock were disposed under transaction code F to satisfy tax withholding related to the vesting of restricted stock units (RSUs). The filing states each RSU converts to one share and that 332,034 shares are issuable upon settlement of RSUs granted to the reporting person. After the reported disposition, the reporting person beneficially owns 437,020 shares (directly held). The disclosure is a routine Section 16 Form 4 reporting an RSU vesting and tax withholding event.
Ajay Marathe, Chief Operating Officer of Enovix Corporation (ENVX), reported a routine Form 4 disclosure covering RSU vesting and associated tax-withholding on September 8, 2025. The filing shows 1,490 shares of common stock were disposed of via withholding to satisfy taxes at an effective price of $9.39 per share. After this transaction, the reporting person beneficially owned 1,159,037 shares, which includes 807,964 shares issuable upon settlement of outstanding restricted stock units (RSUs). The Form 4 was signed by an attorney-in-fact on behalf of Mr. Marathe on September 9, 2025.
Raj Talluri, President and CEO and a director of Enovix Corporation, reported a routine sale of common stock to satisfy tax withholding on RSU vesting. The Form 4 shows a transaction dated 09/08/2025 in which 4,292 shares were disposed of at a price of $9.39 to satisfy tax withholding tied to RSU vesting. After the transaction the reporting person beneficially owned 2,385,918 shares, which includes 1,845,732 shares issuable upon settlement of outstanding RSUs. The filing was signed on behalf of the reporting person on 09/09/2025 by an attorney-in-fact.
Enovix Corporation filed a current report to share that it has updated its investor presentation following the conclusion of its warrant dividend financing. The revised materials are furnished as Exhibit 99.1 and dated September 2025, giving investors an updated overview of the company and the recent financing structure.
The investor presentation is provided under Regulation FD as “furnished,” not “filed,” which means it is not subject to certain liability provisions under the Exchange Act and the Securities Act, nor automatically incorporated into other SEC filings unless specifically referenced.
Enovix Corp (ENVX) reporting person Arthi Chakravarthy, Chief Legal Officer, exercised publicly-traded warrants on 08/27/2025 to acquire 9,513 shares of common stock at an exercise price of $8.75 per share. The warrants were distributed on July 21, 2025 and each entitled the holder to purchase one share at $8.75. Following the transaction the reporting person beneficially owned 437,954 shares, which includes 333,800 shares issuable upon settlement of RSUs. The warrants had an original expiration that was accelerated when an early expiration price condition was met on 08/28/2025, making the warrants cease to be exercisable after 5:00 p.m. ET on 08/29/2025.
Pegah Ebrahimi, a director of Enovix Corporation (ENVX), exercised publicly traded warrants on 08/29/2025 to acquire 6,299 shares of common stock at an exercise price of $8.75 per share. The warrants were originally distributed on July 21, 2025 and were subject to an acceleration provision that caused the expiration to accelerate to August 29, 2025; the warrants ceased to be exercisable prior to 5:00 p.m. New York City time on that date.
After the reported transaction, Ebrahimi beneficially owned 72,939 shares, which includes 22,543 shares issuable upon settlement of restricted stock units. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.